Sandoz Group AG (SDZ.SW) is in Healthcare, Drug Manufacturers - Specialty & Generic, based in Switzerland, listed on Swiss. Market cap 30.12B CHF. 52-week range 47.73 to 75.90 CHF. Trailing P/E 59.5. Data as of 2026-10-09.
Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company has a strategic collaboration ...